These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 2472963

  • 1. Presynaptic muscarinic receptors mediating inhibition of neurogenic contractions in rabbit vas deferens are of the ganglionic M1-type.
    Eltz M, Gmelin G, Wess J, Strohmann C, Tacke R, Mutschler E, Lambrecht G.
    Eur J Pharmacol; 1988 Dec 13; 158(3):233-42. PubMed ID: 2472963
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of field stimulation-induced contractions of rabbit vas deferens by muscarinic receptor agonists: selectivity of McN-A-343 for M1 receptors.
    Davies RH, Scholes HE, Virdi S, Broadley KJ.
    J Pharm Pharmacol; 2001 Apr 13; 53(4):487-96. PubMed ID: 11341365
    [Abstract] [Full Text] [Related]

  • 3. Assessment of selectivity of muscarinic antagonists for M1 and M2 receptors in rabbit isolated vas deferens.
    Eltze M.
    Pharmacology; 1988 Apr 13; 37 Suppl 1():40-7. PubMed ID: 2467317
    [Abstract] [Full Text] [Related]

  • 4. Muscarinic M1 receptor agonist actions of muscarinic receptor agonists in rabbit vas deferens.
    Shannon HE, Sawyer BD, Bemis KG, Bymaster FP, Health I, Mitch CH, Ward JS.
    Eur J Pharmacol; 1993 Feb 23; 232(1):47-57. PubMed ID: 8458395
    [Abstract] [Full Text] [Related]

  • 5. Characterization of the prejunctional muscarinic receptors mediating inhibition of evoked release of endogenous noradrenaline in rabbit isolated vas deferens.
    Grimm U, Fuder H, Moser U, Bümert HG, Mutschler E, Lambrecht G.
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Jan 23; 349(1):1-10. PubMed ID: 8139696
    [Abstract] [Full Text] [Related]

  • 6. Muscarinic M1- and M2-receptors mediating opposite effects on neuromuscular transmission in rabbit vas deferens.
    Eltze M.
    Eur J Pharmacol; 1988 Jul 07; 151(2):205-21. PubMed ID: 2844551
    [Abstract] [Full Text] [Related]

  • 7. Analysis of the muscarinic receptor subtype mediating inhibition of the neurogenic contractions in rabbit isolated vas deferens by a series of polymethylene tetra-amines.
    Budriesi R, Cacciaguerra S, Toro RD, Bolognesi ML, Chiarini A, Minarini A, Rosini M, Spampinato S, Tumiatti V, Melchiorre C.
    Br J Pharmacol; 2001 Mar 07; 132(5):1009-16. PubMed ID: 11226131
    [Abstract] [Full Text] [Related]

  • 8. Effect of extracellular calcium concentration on potency of muscarinic agonists at M1 and M2 receptors in rabbit vas deferens.
    Dörje F, Rettenmayr NM, Mutschler E, Lambrecht G.
    Eur J Pharmacol; 1991 Oct 22; 203(3):417-20. PubMed ID: 1723047
    [Abstract] [Full Text] [Related]

  • 9. Functional determination of McN-A-343 affinity for M1 muscarinic receptors.
    Micheletti R, Schiavone A.
    J Pharmacol Exp Ther; 1990 Apr 22; 253(1):310-4. PubMed ID: 1691785
    [Abstract] [Full Text] [Related]

  • 10. Pathways involved in muscarinic M1 and M2 receptor stimulation in rabbit vas deferens.
    Eltze M.
    Eur J Pharmacol; 1994 Sep 22; 263(1-2):31-7. PubMed ID: 7529712
    [Abstract] [Full Text] [Related]

  • 11. 4-DAMP analogues reveal heterogeneity of M1 muscarinic receptors.
    Micheletti R, Giudici L, Turconi M, Donetti A.
    Br J Pharmacol; 1990 Jul 22; 100(3):395-7. PubMed ID: 1697193
    [Abstract] [Full Text] [Related]

  • 12. Selective inhibition of responses to carbachol and McN-A-343 in the rabbit vas deferens.
    Choo LK, Mitchelson F.
    Clin Exp Pharmacol Physiol; 1990 Sep 22; 17(9):601-11. PubMed ID: 1703935
    [Abstract] [Full Text] [Related]

  • 13. Effects of brucine, a plant alkaloid, on M(1) muscarinic receptors and alpha(1)-adrenoceptors in the rabbit vas deferens preparation.
    Bradley KN, Rowan EG, Harvey AL.
    Toxicon; 2001 Apr 22; 39(4):581-7. PubMed ID: 11024498
    [Abstract] [Full Text] [Related]

  • 14. Affinity profiles of hexahydro-sila-difenidol analogues at muscarinic receptor subtypes.
    Lambrecht G, Feifel R, Wagner-Röder M, Strohmann C, Zilch H, Tacke R, Waelbroeck M, Christophe J, Boddeke H, Mutschler E.
    Eur J Pharmacol; 1989 Sep 01; 168(1):71-80. PubMed ID: 2583233
    [Abstract] [Full Text] [Related]

  • 15. Involvement of muscarinic M2 and M3, but not of M1 and M4 receptors in vagally stimulated contractions of rabbit bronchus/trachea.
    Eltze M, Galvan M.
    Pulm Pharmacol; 1994 Apr 01; 7(2):109-20. PubMed ID: 8081071
    [Abstract] [Full Text] [Related]

  • 16. Himbacine discriminates between putative muscarinic M1 receptor-mediated responses.
    Sagrada A, Duranti P, Giudici L, Schiavone A.
    Life Sci; 1994 Apr 01; 54(17):PL305-10. PubMed ID: 7513038
    [Abstract] [Full Text] [Related]

  • 17. (+/-)-Terodiline: an M1-selective muscarinic receptor antagonist. In vivo effects at muscarinic receptors mediating urinary bladder contraction, mydriasis and salivary secretion.
    Noronha-Blob L, Prosser JC, Sturm BL, Lowe VC, Enna SJ.
    Eur J Pharmacol; 1991 Aug 29; 201(2-3):135-42. PubMed ID: 1724648
    [Abstract] [Full Text] [Related]

  • 18. Modulation of synaptic transmission in autonomic ganglia mediated via the activation of postganglionic muscarinic M1 receptors.
    Galvan M.
    Pharmacology; 1988 Aug 29; 37 Suppl 1():11-6. PubMed ID: 2467314
    [Abstract] [Full Text] [Related]

  • 19. Telenzepine enantiomers block muscarinic M1-receptors with opposite kinetics.
    Eltze M.
    Eur J Pharmacol; 1990 May 03; 180(1):161-8. PubMed ID: 2365000
    [Abstract] [Full Text] [Related]

  • 20. Muscarinic receptor subtypes in the bisected vas deferens of the rat.
    Miranda HF, Duran E, Fernandez E, Pinardi G.
    Gen Pharmacol; 1995 Mar 03; 26(2):387-91. PubMed ID: 7590092
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.